Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients
Nicholas C Chesnaye(Amsterdam Neuroscience), Chiara Somma, Björn Rogland, Aleksandra Musiała, Antonella De Blasio, Carla Barrett, Anna‐Lena Blom, Adamasco Cupisti(University of Pisa), Andreas Jönsson, Christoph Wanner(Universitätsklinikum Würzburg), Hasan Mağın(Karolinska Institutet), Charlotte O'Toole, Marie Evans(Karolinska University Hospital), Butti Alessandra, Alessandra Mele, Cataldo Abaterusso, Fredrik Uhlin(Linköping University), Olof Heimbürger(Karolinska University Hospital), Kitty J. Jager(Amsterdam University Medical Centers), Anna McKeever, C. E. H. Siegert, Alex Còsaro, Andrea Ranghino(Marche Polytechnic University), Asad Ullah, Peter Bárány(Karolinska University Hospital), Sandrine Gaillard(University Medical Center Utrecht), Adelia Sagliocca, Camille Harron, Biagio Di Iorio(Ospedale Civile di Voghera), Carin Wallquist(Skåne University Hospital), Boris Perras, Antonio Bellasi, Karolina Szummer(Karolinska University Hospital), Beate Iwig, Anita Schrander, Alistair Woodman, Tora Almquist(Danderyds sjukhus), Alberto Ferraro, Andrea Stucchi(Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo), Antonello Pani, Friedo W. Dekker(Leiden University Medical Center), Alessandro Naticchia(Agostino Gemelli University Polyclinic), Andreas Schneider, Bastiaan van Dam(Noordwest Ziekenhuisgroep), Angelo Pignataro, Charles Beerenhout, Barbara A. McLaren, Aris Tsalouichos, Anke Torp
Cited by 73
Related Papers
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
|Kidney International|1999|1.8k
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly
|Kidney International|2005|927